Paxil Maker Publishes Study on Children and Antidepressants

By Joanne Silberner

Published June 15, 2004 at 12:00 AM EDT

GlaxoSmithKlein, the manufacturer of the antidepressant Paxil, has released on its company Web site reports of unpublished clinical tests of that drug in children and adolescents suffering from depression. Paxil is not approved for use in children but some doctors have prescribed it off label. SmithKline officials have denied that they selectively disclosed clinical trial findings. This is the first time that this data on Paxil have been made public and NPR's Joanne Silberner looks at whether it will give a different picture of the safety and efficacy of the drug.

Joanne Silberner

Joanne Silberner is a health policy correspondent for National Public Radio. She covers medicine, health reform, and changes in the health care marketplace.

See stories by Joanne Silberner

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.

Donate